Optical grade SiO2 films prepared by HWCVD von Sittinger, V., Höfer, M., Harig, T., Justianto, M., Thiem, H., Vergöhl, M., Schäfer, L.

Volltext

Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma von Hess, G, Keller, U, Scholz, C W, Witzens-Harig, M, Atta, J, Buske, C, Kirschey, S, Ruckes, C, Medler, C, van Oordt, C, Klapper, W, Theobald, M, Dreyling, M

Volltext

Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study von Rule, S, Jurczak, W, Jerkeman, M, Rusconi, C, Trneny, M, Offner, F, Caballero, D, Joao, C, Witzens-Harig, M, Hess, G, Bence-Bruckler, I, Cho, S-G, Thieblemont, C, Zhou, W, Henninger, T, Goldberg, J, Vermeulen, J, Dreyling, M

Volltext

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma von Lisenko, K, Dingeldein, G, Cremer, M, Kriegsmann, M, Ho, A D, Rieger, M, Witzens-Harig, M

Volltext

Optimization of rituximab for the treatment of DLBCL (I): dose-dense rituximab in the DENSE-R-CHOP-14 trial of the DSHNHL von Murawski, N., Pfreundschuh, M., Zeynalova, S., Poeschel, V., Hänel, M., Held, G., Schmitz, N., Viardot, A., Schmidt, C., Hallek, M., Witzens-Harig, M., Trümper, L., Rixecker, T., Zwick, C.

Volltext

Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse von Hahn, M, Böttcher, S, Dietrich, S, Hegenbart, U, Rieger, M, Stadtherr, P, Bondong, A, Schulz, R, Ritgen, M, Schmitt, T, Tran, T H, Görner, M, Herth, I, Luft, T, Schönland, S, Witzens-Harig, M, Zenz, T, Kneba, M, Ho, A D, Dreger, P

Volltext

First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis von Pouyiourou, M., Meyer, A., Stroux, A., Viardot, A., La Rosée, P., Maschmeyer, G., Kämpfe, D., Kahl, C., Vucinic, V., Monecke, A., Hirt, C., Weber, T., Meissner, J., Witzens-Harig, M., Böttcher, S., Schmalenberg, H., Marks, R., Prange-Krex, G., Kroschinsky, F., Hauf, E., Keller, U., Koch, K., Klapper, W., Herold, M., Scholz, Christian W.

Volltext

Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma von Dietrich, S, Weidle, J, Rieger, M, Meissner, J, Radujkovic, A, Ho, A D, Dreger, P, Witzens-Harig, M

Volltext

Performance assessment and benchmarking of autologous peripheral blood stem cell collection with two different apheresis devices von Wuchter, P., Hundemer, M., Schmitt, A., Witzens‐Harig, M., Pavel, P., Hillengass, J., Goldschmidt, H., Ho, A. D., Lisenko, K.

Volltext

Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphoma von Meissner, J., Tichy, D., Katzke, V., Kühn, T., Dietrich, S., Schmitt, T., Ziepert, M., Kuhnt, E., Rixecker, T., Zorn, M., Witzens-Harig, M., Pfreundschuh, M., Ho, A.D.

Volltext

The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor... von Herth, I., Dietrich, S., Benner, A., Hegenbart, U., Rieger, M., Stadtherr, P., Bondong, A., Tran, T.H., Weide, R., Hensel, M., Knauf, W., Franz-Werner, J., Welslau, M., Procaccianti, M., Görner, M., Meissner, J., Luft, T., Schönland, S., Witzens-Harig, M., Zenz, T., Ho, A.D., Dreger, P.

Volltext

Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up von Kornacker, M., Stumm, J., Pott, C., Dietrich, S., Süssmilch, S., Hensel, M., Nickelsen, M., Witzens-Harig, M., Kneba, M., Schmitz, N., Ho, A. D., Dreger, P.

Volltext

Optical grade SiO 2 films prepared by HWCVD von Sittinger, V., Höfer, M., Harig, T., Justianto, M., Thiem, H., Vergöhl, M., Schäfer, L.

Volltext

The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma von Madle, M., Krämer, I., Lehners, N., Schwarzbich, M., Wuchter, P., Herfarth, K., Egerer, G., Ho, A.D., Witzens-Harig, M.

Volltext

Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma von Lisenko, K, McClanahan, F, Schöning, T, Schwarzbich, M A, Cremer, M, Dittrich, T, Ho, A D, Witzens-Harig, M

Volltext

Rituximab-Erhaltungstherapie vs. erneute Rituximab-Behandlung im Rezidiv bei Patienten mit follikulärem Lymphom und niedriger Krankheitsmasse von Witzens-Harig, M

Volltext

Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatme... von McClanahan, F., Hielscher, T., Rieger, M., Hensel, M., Bentz, M., Schmidt-Wolf, I., Käbisch, A., Salwender, H., Dürk, H., Staiger, H., Mandel, T., Neben, K., Hillengass, J., Leo, E., Krämer, A., Ho, A.D., Witzens-Harig, M.

Volltext

La tâche comme outil pédagogique au cœur du FLE : analyse comparative des manuels de l’enseignement moyen de première et deuxième génération von Khadra SEBBAR & Fatima Zohra HARIG-BENMOSTEFA

Volltext

Les formes énonciatives et la relation interpersonnelle dans les Lettres persanes de Montesquieu von Bouchikhi, Nawal, Harig Benmostefa, Fatima Zohra, Chelli, Rachida

Volltext

Treatment of Diversion Colitis with Short-Chain-Fatty Acid Irrigation von Harig, James M, Soergel, Konrad H, Komorowski, Richard A, Wood, Carol M

Volltext